Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
Patents for C07D 239 - Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings (42,619)
10/2009
10/27/2009CA2361174C 4-amino-quinazoline and quinoline derivatives having an inhibitory effect on signal transduction mediated by tyrosine kinases
10/27/2009CA2318145C Sulfonylamino derivatives which inhibit matrix-degrading metalloproteinases
10/22/2009WO2009129291A1 2-(substituted phenyl)-6-hydroxy or alkoxy-5-substituted-4-pyrimidinecarboxylates and their use as herbicides
10/22/2009WO2009129267A2 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/22/2009WO2009128512A1 Method for producing pyrimidine compound
10/22/2009WO2009128091A2 Crystalline form of(7-[4-(4-fluorophenyl)-6-isopropyl-2-(n- methyl-n-methylsulfonylamino)pyrimidin-5-yl]-(3r,5s)- dihydroxy-(e)-6-heptenoic acid intermediate, process for preparing the same and use thereof
10/22/2009WO2009127723A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
10/22/2009WO2009127642A2 Use of lrrk2 inhibitors for neurodegenerative diseases
10/22/2009WO2009127378A1 Herbicidal compounds based on n-azinyl-n'-phenylsulfonylureas
10/22/2009WO2009127338A1 Oxo-heterocyclic substituted carboxylic acid derivates and the use thereof
10/22/2009US20090264654 Process for the preparation of pyrimidine compounds
10/22/2009US20090264649 Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors
10/22/2009US20090264452 2-(Phenylamino)-Pyrimidin-5-Amides As Cannabinoid 2 Receptors Modulators for the Treatment of Immune or Inflammatory Disorders
10/22/2009US20090264447 Pyrimidine compounds for combating pathogenic fungi and cancer
10/22/2009US20090264429 Aryl - Hydroxyethylamino - Pyrimidines and Triazines as Modulators of Fatty Acid amide Hydrolase
10/22/2009US20090264424 Vanilloid receptor ligands and their use in treatments
10/22/2009US20090264405 Cetp Inhibitors
10/22/2009US20090264401 Substituted pyrimidin-5-carboxamides 281
10/22/2009US20090264293 2-(substituted phenyl)-6-hydroxy or alkoxy-5-substituted-4-pyrimidinecarboxylates and their use as herbicides
10/22/2009CA2721785A1 New arylsulphonylglycine derivatives, the preparation thereof and their use as medicaments
10/22/2009CA2721371A1 Small molecule inhibitors of the pleckstrin homology domain and methods for using same
10/22/2009CA2720848A1 2-(substituted phenyl)-6-hydroxy or alkoxy-5-substituted-4-pyrimidinecarboxylates and their use as herbicides
10/21/2009EP2110019A1 Herbicidal compounds based on N-Azinyl-N'-phenylsulfonylureas
10/21/2009EP2109605A2 2- [(phenylamino) -pyrimidin-4ylamin0] -cyclopentane carboxamide derivatives and related compounds as inhibitors of kinases of the cell cycle for the treatment of cancer
10/21/2009EP2109602A2 Tetracycline derivatives for the treatment of bacterial, viral and parasitic infections
10/21/2009EP1979320B1 PIPERAZINES AND PIPERIDINES AS mGluR5 POTENTIATORS
10/21/2009EP1322624B1 Arylalkane-sulfonamides having endothelin-antagonist activity
10/21/2009EP0900200B9 Pharmaceutical compositions for prevention and treatment of central nervous system disorders
10/21/2009CN101563338A MAPK/ERK kinase inhibitors
10/21/2009CN101563328A Substituted heteroaryl pyridopyrimidone derivatives
10/21/2009CN101563327A Pyrimidine kinase inhibitors
10/21/2009CN101559062A Quinazoline derivatives which promote the release of parathyroid hormone
10/20/2009US7605166 Synergistic mixture of methotrexate and integrin antigen or antibody
10/20/2009US7605165 Phenylalanine derivatives
10/20/2009US7605163 Benzoyl-piperazine derivatives
10/20/2009US7605159 Cathepsin cysteine protease inhibitors and their use
10/20/2009CA2721712A1 Herbicidal compounds based on n-azinyl-n'-phenylsulfonylureas
10/20/2009CA2585898C Use of (2s,3s,5s)-5-(n-(n-((n-methyl-n-((2-isopropyl-4-thaizolyl)methyl)amino)-carbonyl)valinyl)amino)-2-(n-((5-thiazolyl)methoxycarbonyl)amino)-1,6-diphenyl-3-hydroxyhexane in combination with another protease inhibitor for treating hiv infection
10/20/2009CA2537373C Selective synthesis of cf3-substituted pyrimidines
10/20/2009CA2456127C Cysteine protease inhibitors with 2-cyano-4-amino-pyrimidine structure and cathepsin k inhibitory activity for the treatment of inflammations and other diseases
10/20/2009CA2407371C Quinazoline derivatives for the treatment of tumours
10/20/2009CA2368843C Neurotrophic substituted pyrimidines
10/15/2009WO2009126831A1 Ruthenium olefin metathesis catalysts bearing n-heterocyclic carbene ligands with substituted backbone
10/15/2009WO2009126639A1 Crystalline salt forms of antifolate compounds and methods of manufacturing thereof
10/15/2009WO2009126637A1 Antifolate compositions
10/15/2009WO2009126584A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/15/2009WO2009126515A1 Compounds and compositions as protein kinase inhibitors
10/15/2009WO2009125870A1 Pyrimidine, pyridine and triazine derivatives as maxi-k channel openers.
10/15/2009WO2009042138A9 Alkylthio pyrimidines as crth2 antagonists
10/15/2009WO2009007984A3 An improved process for erlotinib hydrochloride
10/15/2009WO2008059519A3 A process for the preparation of intermediates of rosuvastatin
10/15/2009US20090258888 Pyrimidine Derivatives
10/15/2009US20090258884 Substituted amides
10/15/2009US20090258882 2,4-Substituted Quinazolines as Lipid Kinase Inhibitors
10/15/2009US20090258871 Aza-Substituted Spiro Derivatives
10/15/2009US20090258868 Heterocyclic aspartyl protease inhibitors
10/15/2009CA2720946A1 Compounds and compositions as protein kinase inhibitors
10/15/2009CA2720530A1 Sulfonamides
10/15/2009CA2719538A1 Gem-disubstituted and spirocyclic amino pyridines/pyrimidines as cell cycle inhibitors
10/15/2009CA2718544A1 Crystalline salt forms of antifolate compounds and methods of manufacturing thereof
10/15/2009CA2718330A1 Antifolate compositions
10/14/2009EP1720829B1 Derivatives of heteroaryl-alkylcarbamates, preparation method thereof and use of same as faah enzyme inhibitors
10/14/2009CN101558048A Amino quinazolines derivatives wuth blood platelet reducing properties
10/14/2009CN101558047A Process for the preparation of substituted cynophenoxy-pyrimidinyloxy-phenyl acrylate derivatives
10/14/2009CN101558046A Morpholino pyrimidine derivatives useful in the treatment of proliferative disorders
10/14/2009CN101555233A Improved production process of 1,3-Dimethyl-3,4,5,6-tetrahydro-2(1H)-pyrimidinone
10/14/2009CN100548991C Compound in 4,4-dibasic-3,4-dihydro-2(1H) quinazolone category
10/13/2009US7601836 Pyrido[2,3-D]pyrimidine inhibitors of phosphodiesterase (PDE) 7
10/13/2009US7601730 Carboxylic acid derivatives, their preparation and use
10/13/2009US7601729 Matrix metalloproteinase inhibitors
10/13/2009US7601715 HIV inhibitors
10/13/2009US7601714 Pyrimidine derivatives useful as inhibitors of PKC-theta
10/13/2009US7601713 Kinase inhibitors and their uses
10/13/2009US7601702 Dutpase Inhibitors
10/13/2009US7601674 α-oxygenated or α-thiolated carboxylic acid phenethylamide derivatives
10/13/2009CA2384037C Pyrazolo[4,3-d]pyrimidines
10/08/2009WO2009124013A1 Compositions and mehtods for inhibition of hepatocyte growth factory receptor c-met signaling
10/08/2009WO2009123967A1 5,6,7,8-tetrahydroquinazolin-2-amine derivatives and related compounds as histamine h4 receptor modulators for the treatment of asthma
10/08/2009WO2009123221A1 Pyrimidine derivative having cell-protecting activity and use thereof
10/08/2009WO2009122180A1 Pyrimidine derivatives capable of inhibiting one or more kinases
10/08/2009WO2009096667A3 Novel quinazoline-2,4-dione derivative, and medical compositions for the prophylaxis and treatment of cranial nerve disease containing the same
10/08/2009US20090253950 Radioactive member and method of making
10/08/2009US20090253909 Process for preparation of 6, 7-bis (2-methoxyethoxy) quinazolin-4-one
10/08/2009US20090253905 Process for the preparation of onium salts with alkyl- or arylsulfonate anions or alkyl- or arylcarboxylate anions having a low halide content
10/08/2009US20090253723 Protein kinase inhibitors
10/08/2009US20090253719 Crystalline salt forms of antifolate compounds and methods of manufacturing thereof
10/08/2009US20090253694 Fused hetrocyclic compounds
10/08/2009US20090253659 Cycloalkylidene Compounds As Modulators of Estrogen Receptor
10/08/2009US20090253645 Methods and materials for treating and preventing inflammation of mucosal tissue
10/08/2009CA2720350A1 Compositions and methods for inhibition of hepatocyte growth factor receptor c-met signaling
10/08/2009CA2720049A1 Pyrimidine derivative having cell protecting effect and uses thereof
10/07/2009EP2106400A2 Benzoquinazole derivatives
10/07/2009EP1309566B1 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
10/07/2009EP0840736B1 Improved synthons for the synthesis and deprotection of peptide nucleic acids under mild conditions
10/07/2009CN101553475A Hydroxamates as inhibitors of histone deacetylase
10/07/2009CN101553472A Tetrahydronaphthaline derivatives, methods for the production and use thereof as anti-inflammatory agents
10/07/2009CN101550109A Design and synthesis of novel tubulin polymerization inhibitors: benzoylphenylurea (bpu) sulfur analogs
10/07/2009CN101550108A Preparation method of environmental-friendly high-purity 2,4,6-trichloropyrimidine
10/07/2009CN100546997C Process for preparing cytidine compound
10/06/2009US7598423 e.g. 3-{[4-(4-acetyl-3-hydroxy-2-propylphenoxymethyl)-phenyl]-(S)-hydroxymethyl}-benzoic acid; anxiolytic, neuroleptic agent and antidepressant as glutamate receptor agonist; antiinflammatory agent as leukotriene receptor agonist;
1 ... 90 91 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 ... 427